CRYSTAL LUFFMAN: Open Payments
NPI 1578524070 · ELKIN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 69 payments from 8 companies in 2025. Trend: 2023 $673 · 2024 $1,299 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $362 |
| Lundbeck LLC | 16 | $241 |
| ABBVIE INC. | 19 | $180 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Alkermes, Inc. | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: AUSTEDO XR, REXULTI, VRAYLAR, Auvelity, ARISTADA, HETLIOZ, INGREZZA, FANAPT.
Industry payments across NC — which companies pay providers there.
